Variant report
Variant | nsv881014 |
---|---|
Chromosome Location | chr5:29569175-29631637 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:93)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BRCA1 | chr5:29587962-29588174 | Hela-S3 | cervix: | n/a | n/a |
2 | CEBPB | chr5:29597920-29598079 | HepG2 | liver: | n/a | n/a |
3 | CEBPB | chr5:29587991-29588728 | Hela-S3 | cervix: | n/a | n/a |
4 | CEBPB | chr5:29630539-29630789 | HepG2 | liver: | n/a | n/a |
5 | CEBPB | chr5:29614349-29614730 | Hela-S3 | cervix: | n/a | n/a |
6 | CTCF | chr5:29597260-29597410 | HCPEpiC | choroid plexus: | n/a | n/a |
7 | CTCF | chr5:29604300-29604341 | Kidney_OC | kidney: | n/a | n/a |
8 | CTCF | chr5:29600742-29600770 | ProgFib | skin: | n/a | n/a |
9 | E2F4 | chr5:29616472-29616776 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | EP300 | chr5:29614493-29614560 | GM12878 | blood: | n/a | n/a |
11 | EP300 | chr5:29617734-29617895 | GM12878 | blood: | n/a | n/a |
12 | EP300 | chr5:29590439-29590517 | K562 | blood: | n/a | n/a |
13 | EP300 | chr5:29595145-29595190 | K562 | blood: | n/a | n/a |
14 | EP300 | chr5:29587974-29588741 | Hela-S3 | cervix: | n/a | n/a |
15 | EP300 | chr5:29606680-29606775 | K562 | blood: | n/a | n/a |
16 | EP300 | chr5:29614431-29614795 | Hela-S3 | cervix: | n/a | n/a |
17 | FOS | chr5:29588092-29588292 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | FOS | chr5:29614318-29614779 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | FOS | chr5:29614369-29614731 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | FOS | chr5:29588032-29588235 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | FOS | chr5:29587998-29588768 | Hela-S3 | cervix: | n/a | n/a |
22 | FOS | chr5:29614333-29614724 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | FOS | chr5:29614335-29614781 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | FOS | chr5:29588026-29588636 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | FOSL2 | chr5:29587980-29588275 | MCF-7 | breast: | n/a | n/a |
26 | GATA3 | chr5:29587914-29588292 | MCF-7 | breast: | n/a | n/a |
27 | JUN | chr5:29588921-29589044 | H1-hESC | embryonic stem cell: | n/a | n/a |
28 | JUN | chr5:29587909-29588757 | Hela-S3 | cervix: | n/a | n/a |
29 | JUN | chr5:29570495-29570505 | HepG2 | liver: | n/a | n/a |
30 | JUN | chr5:29614461-29614561 | HepG2 | liver: | n/a | chr5:29614504-29614517 |
31 | JUND | chr5:29629901-29629968 | H1-hESC | embryonic stem cell: | n/a | n/a |
32 | JUND | chr5:29587921-29588732 | Hela-S3 | cervix: | n/a | n/a |
33 | JUND | chr5:29625360-29625551 | HepG2 | liver: | n/a | n/a |
34 | MAFF | chr5:29631384-29631581 | HepG2 | liver: | n/a | chr5:29631493-29631511 |
35 | MAFK | chr5:29631406-29631606 | HepG2 | liver: | n/a | chr5:29631497-29631511 |
36 | MAFK | chr5:29607681-29607767 | H1-hESC | embryonic stem cell: | n/a | n/a |
37 | MAFK | chr5:29625362-29625405 | K562 | blood: | n/a | n/a |
38 | MAFK | chr5:29629333-29629449 | HepG2 | liver: | n/a | n/a |
39 | MAFK | chr5:29631406-29631606 | HepG2 | liver: | n/a | chr5:29631497-29631511 |
40 | MAFK | chr5:29586076-29586276 | HepG2 | liver: | n/a | n/a |
41 | MAX | chr5:29573145-29573234 | NB4 | blood: | n/a | n/a |
42 | MAZ | chr5:29599387-29599839 | HepG2 | liver: | n/a | n/a |
43 | MAZ | chr5:29609132-29609176 | HepG2 | liver: | n/a | n/a |
44 | MAZ | chr5:29587206-29587374 | Hela-S3 | cervix: | n/a | n/a |
45 | MYC | chr5:29593746-29593809 | H1-hESC | embryonic stem cell: | n/a | n/a |
46 | MYC | chr5:29614411-29614644 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | POLR2A | chr5:29580937-29580997 | ProgFib | skin: | n/a | n/a |
48 | POLR2A | chr5:29615453-29615652 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | POLR2A | chr5:29605005-29605065 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | POLR2A | chr5:29587462-29587474 | A549 | lung: | n/a | n/a |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:29620035..29622604-chr5:29624083..29625819,2 | K562 | blood: | |
2 | chr5:29615746..29618032-chr5:29623108..29625004,2 | K562 | blood: | |
3 | chr16:27487589..27488219-chr5:29570534..29571280,2 | MCF-7 | breast: | |
4 | chr16:89785981..89788099-chr5:29571782..29574694,2 | MCF-7 | breast: | |
5 | chr5:29623807..29626845-chr5:29627046..29630345,3 | MCF-7 | breast: | |
6 | chr5:29620035..29622604-chr5:29624083..29625819,2 | K562 | blood: | |
7 | chr5:29623807..29626845-chr5:29627046..29630345,3 | MCF-7 | breast: | |
8 | chr5:29615746..29618032-chr5:29623108..29625004,2 | K562 | blood: | |
9 | chr5:29628564..29631486-chr5:29634106..29636111,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
UBL5P1 | TF binding region |
ENSG00000077235 | chromatin interactions |
ENSG00000158805 | chromatin interactions |
ENSG00000075399 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10061669 | chr5:29569175-29569176 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs114846831 | chr5:29569176-29569177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577845177 | chr5:29569201-29569202 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556319592 | chr5:29569220-29569221 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs6885444 | chr5:29569248-29569249 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs527956882 | chr5:29569353-29569354 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs17571587 | chr5:29569364-29569365 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs11749390 | chr5:29569377-29569378 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189986378 | chr5:29569428-29569429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs201620000 | chr5:29569463-29569464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113667263 | chr5:29569464-29569465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs370788872 | chr5:29569465-29569466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs180738743 | chr5:29569506-29569507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539003704 | chr5:29569530-29569531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs139479173 | chr5:29569552-29569553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75169033 | chr5:29569582-29569583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149665163 | chr5:29569618-29569619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554443688 | chr5:29569631-29569632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs573805450 | chr5:29569637-29569638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576145930 | chr5:29569716-29569717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs556177305 | chr5:29569807-29569808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368052990 | chr5:29569817-29569818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs201977213 | chr5:29569842-29569843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564987817 | chr5:29569860-29569861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576891915 | chr5:29569888-29569889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34374924 | chr5:29569905-29569906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187406217 | chr5:29569920-29569921 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541145219 | chr5:29569935-29569936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559364991 | chr5:29569969-29569970 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529717426 | chr5:29570004-29570005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114422772 | chr5:29570006-29570007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549658075 | chr5:29570044-29570045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561611894 | chr5:29570085-29570086 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs74736198 | chr5:29570109-29570110 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs74615587 | chr5:29570169-29570170 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191821497 | chr5:29570196-29570197 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs17634115 | chr5:29570198-29570199 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368874433 | chr5:29570201-29570202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs573683278 | chr5:29570247-29570248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs184013923 | chr5:29570275-29570276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538722154 | chr5:29570296-29570297 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547505253 | chr5:29570299-29570300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565688501 | chr5:29570305-29570306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536252716 | chr5:29570374-29570375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554433543 | chr5:29570386-29570387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs6890975 | chr5:29570398-29570399 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs116530121 | chr5:29570407-29570408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs73750487 | chr5:29570470-29570471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142206431 | chr5:29570489-29570490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs3925375 | chr5:29570528-29570529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29567600-29569800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr5:29568800-29569200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr5:29569200-29569400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr5:29569400-29570200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr5:29569800-29570800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr5:29570200-29571200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr5:29570800-29572400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
8 | chr5:29571200-29571400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr5:29571400-29571600 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr5:29571600-29571800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr5:29571800-29572000 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr5:29572000-29572200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr5:29587200-29589400 | Enhancers | Hela-S3 | cervix |
14 | chr5:29602800-29603600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr5:29613600-29614200 | Enhancers | Hela-S3 | cervix |
16 | chr5:29614200-29614600 | Weak transcription | Hela-S3 | cervix |
17 | chr5:29614600-29615200 | Enhancers | Hela-S3 | cervix |